{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:50:37Z","timestamp":1792691437955,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl. Stroke Res."],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12975-025-01357-x","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T09:16:07Z","timestamp":1747732567000},"page":"2272-2289","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Exploring the Efficacy and Safety of Argatroban as an Adjunct to Antiplatelet Therapy in Ischemic Stroke Patients: A Systematic Review and Meta-analysis"],"prefix":"10.1007","volume":"16","author":[{"given":"Yousr","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa Hossam El Din","family":"Moawad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulnaz","family":"Bahtiyarova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Younes","family":"Nabgouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Elkholy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reham M.","family":"Wagih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Serag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibraheem M.","family":"Alkhawaldeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Abouzid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Elsayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,20]]},"reference":[{"issue":"10","key":"1357_CR1","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1080\/01616412.2018.1495882","volume":"40","author":"L Chen","year":"2018","unstructured":"Chen L, Cao S, Yang J. Argatroban plus aspirin versus aspirin in acute ischemic stroke. Neurol Res. 2018;40(10):862\u20137.","journal-title":"Neurol Res"},{"issue":"3","key":"1357_CR2","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1161\/STR.0b013e318284056a","volume":"44","author":"EC Jauch","year":"2013","unstructured":"Jauch EC, Saver JL, Adams HP Jr, Bruno A, Connors JJ, Demaerschalk BM, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2013;44(3):870\u2013947.","journal-title":"Stroke"},{"issue":"1","key":"1357_CR3","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1136\/jnnp-2014-308327","volume":"86","author":"P Seners","year":"2015","unstructured":"Seners P, Turc G, Oppenheim C, Baron JC. Incidence, causes and predictors of neurological deterioration occurring within 24 h following acute ischaemic stroke: a systematic review with pathophysiological implications. J Neurol Neurosurg Psychiatry. 2015;86(1):87\u201394.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"1357_CR4","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1161\/STROKEAHA.119.027239","volume":"51","author":"H Li","year":"2020","unstructured":"Li H, Dai Y, Wu H, Luo L, Wei L, Zhou L, et al. Predictors of early neurologic deterioration in acute pontine infarction. Stroke. 2020;51(2):637\u201340.","journal-title":"Stroke"},{"issue":"10","key":"1357_CR5","first-page":"Cd000024","volume":"10","author":"X Wang","year":"2021","unstructured":"Wang X, Ouyang M, Yang J, Song L, Yang M, Anderson CS. Anticoagulants for acute ischaemic stroke. Cochrane Database Syst Rev. 2021;10(10):Cd000024.","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"1357_CR6","first-page":"Cd001342","volume":"2012","author":"EL De Schryver","year":"2012","unstructured":"De Schryver EL, Algra A, Kappelle LJ, van Gijn J, Koudstaal PJ. Vitamin K antagonists versus antiplatelet therapy after transient ischaemic attack or minor ischaemic stroke of presumed arterial origin. Cochrane Database Syst Rev. 2012;2012(9):Cd001342.","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"1357_CR7","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1177\/2396987319841187","volume":"4","author":"CJ Klijn","year":"2019","unstructured":"Klijn CJ, Paciaroni M, Berge E, Korompoki E, K\u00f5rv J, Lal A, et al. Antithrombotic treatment for secondary prevention of stroke and other thromboembolic events in patients with stroke or transient ischemic attack and non-valvular atrial fibrillation: A European Stroke Organisation guideline. Eur Stroke J. 2019;4(3):198\u2013223.","journal-title":"Eur Stroke J"},{"issue":"7","key":"1357_CR8","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1161\/01.STR.0000131549.20581.ba","volume":"35","author":"MP LaMonte","year":"2004","unstructured":"LaMonte MP, Nash ML, Wang DZ, Woolfenden AR, Schultz J, Hursting MJ, et al. Argatroban anticoagulation in patients with acute ischemic stroke (ARGIS-1): a randomized, placebo-controlled safety study. Stroke. 2004;35(7):1677\u201382.","journal-title":"Stroke"},{"issue":"6","key":"1357_CR9","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1161\/STROKEAHA.117.016720","volume":"48","author":"AD Barreto","year":"2017","unstructured":"Barreto AD, Ford GA, Shen L, Pedroza C, Tyson J, Cai C, et al. Randomized, multicenter trial of ARTSS-2 (argatroban with recombinant tissue plasminogen activator for acute stroke). Stroke. 2017;48(6):1608\u201316.","journal-title":"Stroke"},{"issue":"9","key":"1357_CR10","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1056\/NEJMoa2314779","volume":"391","author":"O Adeoye","year":"2024","unstructured":"Adeoye O, Broderick J, Derdeyn CP, Grotta JC, Barsan W, Bentho O, et al. Adjunctive intravenous argatroban or eptifibatide for ischemic stroke. N Engl J Med. 2024;391(9):810\u201320.","journal-title":"N Engl J Med"},{"key":"1357_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372: n71.","journal-title":"BMJ"},{"key":"1357_CR12","doi-asserted-by":"publisher","unstructured":"Cumpston M, Li T, Page MJ, Chandler J, Welch VA, Higgins JP et al. Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane database of systematic reviews. 2019;2019(10). https:\/\/doi.org\/10.1002\/14651858.ED000142.","DOI":"10.1002\/14651858.ED000142"},{"issue":"2","key":"1357_CR13","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1001\/jamaneurol.2023.5093","volume":"81","author":"X Zhang","year":"2024","unstructured":"Zhang X, Zhong W, Xue R, Jin H, Gong X, Huang Y, et al. Argatroban in patients with acute ischemic stroke with early neurological deterioration: a randomized clinical trial. JAMA Neurol. 2024;81(2):118\u201325.","journal-title":"JAMA Neurol"},{"key":"1357_CR14","unstructured":"Wells G, Shea B, O\u2019Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2011. http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp"},{"key":"1357_CR15","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.","journal-title":"BMJ"},{"key":"1357_CR16","doi-asserted-by":"publisher","unstructured":"Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5(1). https:\/\/doi.org\/10.1186\/1471-2288-5-13","DOI":"10.1186\/1471-2288-5-13"},{"issue":"1","key":"1357_CR17","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1186\/s12883-021-02435-x","volume":"21","author":"PF Wang","year":"2021","unstructured":"Wang PF, Sun ZR, Yu JC, Geng N, Liu LY, Zhu LN, et al. Early argatroban and antiplatelet combination therapy in acute non-lacunar single subcortical infarct associated with mild intracranial atherosclerosis. BMC Neurol. 2021;21(1):440.","journal-title":"BMC Neurol"},{"key":"1357_CR18","first-page":"e924593","volume":"26","author":"S Liu","year":"2020","unstructured":"Liu S, Liu P, Wang P, Zhang F, Wang L, Wang Y, et al. Argatroban increased the basal vein drainage and improved outcomes in acute paraventricular ischemic stroke patients. Med Sci Monit. 2020;26:e924593.","journal-title":"Med Sci Monit"},{"issue":"2","key":"1357_CR19","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1161\/STROKEAHA.115.011250","volume":"47","author":"T Wada","year":"2016","unstructured":"Wada T, Yasunaga H, Horiguchi H, Matsubara T, Fushimi K, Nakajima S, et al. Outcomes of argatroban treatment in patients with atherothrombotic stroke: observational nationwide study in Japan. Stroke. 2016;47(2):471\u20136.","journal-title":"Stroke"},{"issue":"1","key":"1357_CR20","doi-asserted-by":"publisher","first-page":"108151","DOI":"10.1016\/j.jstrokecerebrovasdis.2024.108151","volume":"34","author":"J Yan","year":"2025","unstructured":"Yan J, Yu S, Feng H, Zhao H, Dong X, Xu Q, et al. Safety and efficacy of argatroban combined with antiplatelet therapy for acute mild-to-moderate ischemic stroke with large artery atherosclerosis. J Stroke Cerebrovasc Dis. 2025;34(1):108151.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"1","key":"1357_CR21","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1161\/STROKEAHA.121.036356","volume":"53","author":"J Xu","year":"2022","unstructured":"Xu J, Xu X, Wang H, He L, Liu Q, Du Y, et al. Dual antiplatelet therapy plus argatroban prevents early neurological deterioration in branch atherosclerosis disease. Stroke. 2022;53(1):e19\u201320.","journal-title":"Stroke"},{"issue":"7","key":"1357_CR22","doi-asserted-by":"publisher","first-page":"e2664","DOI":"10.1002\/brb3.2664","volume":"12","author":"XQ Li","year":"2022","unstructured":"Li XQ, Hou XW, Cui Y, Tian XF, Wang XH, Zhou ZH, et al. Safety and preliminary efficacy of argatroban plus dual antiplatelet therapy for acute mild to moderate ischemic stroke with large artery atherosclerosis. Brain Behav. 2022;12(7):e2664.","journal-title":"Brain Behav"},{"key":"1357_CR23","doi-asserted-by":"publisher","first-page":"107602962090413","DOI":"10.1177\/1076029620904131","volume":"26","author":"LS Zhou","year":"2020","unstructured":"Zhou LS, Li XQ, Zhou ZH, Chen HS. Effect of argatroban combined with dual antiplatelet therapy on early neurological deterioration in acute minor posterior circulation ischemic stroke. Clin Appl Thromb Hemost. 2020;26:1076029620904131.","journal-title":"Clin Appl Thromb Hemost"},{"key":"1357_CR24","doi-asserted-by":"publisher","first-page":"1363358","DOI":"10.3389\/fneur.2024.1363358","volume":"15","author":"X Jin","year":"2024","unstructured":"Jin X, Li X, Zhang H, Yao X, Gu Y, Pei S, et al. The effect of argatroban on early neurological deterioration and outcomes in minor ischemic stroke: preliminary findings. Front Neurol. 2024;15:1363358.","journal-title":"Front Neurol"},{"key":"1357_CR25","doi-asserted-by":"publisher","unstructured":"Sun M, Li G, Du Y, Cheng J, Zhu Q, Shi Z. Efficacy of antiplatelet drugs combined with Argatroban in treating acute ischemic stroke and its impact on patients' coagulation function and neurological function: a preliminary trial. Int J Neurosci. 2024:1\u20138. https:\/\/doi.org\/10.1080\/00207454.2024.2303370.","DOI":"10.1080\/00207454.2024.2303370"},{"issue":"8","key":"1357_CR26","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.03.016","volume":"27","author":"H Oguro","year":"2018","unstructured":"Oguro H, Mitaki S, Takayoshi H, Abe S, Onoda K, Yamaguchi S. Retrospective analysis of argatroban in 353 patients with acute noncardioembolic stroke. J Stroke Cerebrovasc Dis. 2018;27(8):2175\u201381.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"1357_CR27","doi-asserted-by":"publisher","unstructured":"Sandercock PA, Counsell C, Gubitz GJ, Tseng MC. Antiplatelet therapy for acute ischaemic stroke. Cochrane Database Syst Rev. 2008(3). https:\/\/doi.org\/10.1002\/14651858.CD000029.pub2.","DOI":"10.1002\/14651858.CD000029.pub2"},{"issue":"6","key":"1357_CR28","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1212\/WNL.0b013e31829e6f37","volume":"81","author":"A Ois","year":"2013","unstructured":"Ois A, Cuadrado-Godia E, Rodr\u00edguez-Campello A, Giralt-Steinhauer E, Jim\u00e9nez-Conde J, Lopez-Cui\u00f1a M, et al. Relevance of stroke subtype in vascular risk prediction. Neurology. 2013;81(6):575\u201380.","journal-title":"Neurology"},{"issue":"5","key":"1357_CR29","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S1474-4422(07)70079-0","volume":"6","author":"KS Wong","year":"2007","unstructured":"Wong KS, Chen C, Ng PW, Tsoi TH, Li HL, Fong WC, et al. Low-molecular-weight heparin compared with aspirin for the treatment of acute ischaemic stroke in Asian patients with large artery occlusive disease: a randomised study. Lancet Neurol. 2007;6(5):407\u201313.","journal-title":"Lancet Neurol"},{"key":"1357_CR30","doi-asserted-by":"crossref","unstructured":"The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Int Stroke Trial Collab Group Lancet. 1997;349(9065):1569\u201381.","DOI":"10.1016\/S0140-6736(97)04011-7"},{"issue":"5","key":"1357_CR31","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1161\/STROKEAHA.119.024786","volume":"50","author":"D Kim","year":"2019","unstructured":"Kim D, Park JM, Kang K, Cho YJ, Hong KS, Lee KB, et al. Dual versus mono antiplatelet therapy in large atherosclerotic stroke. Stroke. 2019;50(5):1184\u201392.","journal-title":"Stroke"},{"issue":"5","key":"1357_CR32","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1177\/1076029614551823","volume":"21","author":"C Wang","year":"2015","unstructured":"Wang C, Yi X, Zhang B, Liao D, Lin J, Chi L. Clopidogrel plus aspirin prevents early neurologic deterioration and improves 6-month outcome in patients with acute large artery atherosclerosis stroke. Clin Appl Thromb Hemost. 2015;21(5):453\u201361.","journal-title":"Clin Appl Thromb Hemost"},{"issue":"7","key":"1357_CR33","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.01.022","volume":"23","author":"X Yi","year":"2014","unstructured":"Yi X, Lin J, Wang C, Zhang B, Chi W. A comparative study of dual versus monoantiplatelet therapy in patients with acute large-artery atherosclerosis stroke. J Stroke Cerebrovasc Dis. 2014;23(7):1975\u201381.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"1357_CR34","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.brainresbull.2021.07.020","volume":"175","author":"WJ Tu","year":"2021","unstructured":"Tu WJ, Chao BH, Ma L, Yan F, Cao L, Qiu H, et al. Case-fatality, disability and recurrence rates after first-ever stroke: a study from bigdata observatory platform for stroke of China. Brain Res Bull. 2021;175:130\u20135.","journal-title":"Brain Res Bull"},{"issue":"6","key":"1357_CR35","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1055\/s-2007-996131","volume":"23","author":"S Kobayashi","year":"1997","unstructured":"Kobayashi S, Tazaki Y. Effect of the thrombin inhibitor argatroban in acute cerebral thrombosis. Semin Thromb Hemost. 1997;23(6):531\u20134.","journal-title":"Semin Thromb Hemost"},{"issue":"175","key":"1357_CR36","doi-asserted-by":"publisher","first-page":"185","DOI":"10.24976\/Discov.Med.202335175.19","volume":"35","author":"S Xu","year":"2023","unstructured":"Xu S, Zhang W, Zhang Y, Xu Z, Wu T. Efficacy and prognosis of adjuvant argatroban treatment in acute ischemic stroke patients with early neurological deterioration. Discov Med. 2023;35(175):185\u201392.","journal-title":"Discov Med"},{"issue":"8","key":"1357_CR37","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1001\/jama.2023.0550","volume":"329","author":"HS Chen","year":"2023","unstructured":"Chen HS, Cui Y, Zhou ZH, Dai YJ, Li GH, Peng ZL, et al. Effect of argatroban plus intravenous alteplase vs intravenous alteplase alone on neurologic function in patients with acute ischemic stroke: the ARAIS randomized clinical trial. JAMA. 2023;329(8):640\u201350.","journal-title":"JAMA"}],"container-title":["Translational Stroke Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-025-01357-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12975-025-01357-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-025-01357-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T20:03:11Z","timestamp":1762632191000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12975-025-01357-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,20]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1357"],"URL":"https:\/\/doi.org\/10.1007\/s12975-025-01357-x","relation":{},"ISSN":["1868-4483","1868-601X"],"issn-type":[{"value":"1868-4483","type":"print"},{"value":"1868-601X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,20]]},"assertion":[{"value":"7 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}